Literature DB >> 5316262

Heterogeneity of the cellular immune response. II. The role of adjuvant, lymphocyte stimulation in cutaneous basophil hypersensitivity.

R C Bast, B A Simpson, H F Dvorak.   

Abstract

Antigen-mediated stimulation of thymidine incorporation was demonstrated in lymph node cells from guinea pigs immunized with 100 microg human serum albumin in either Freund's incomplete or Freund's complete adjuvant. Animals receiving HSA in IFA exhibited both cutaneous basophil (Jones-Mote) hypersensitivity and lymphocyte stimulation at 1, but not at 6 wk after immunization. Significant stimulation required >/= 10 microg HSA/ml of culture. Sensitization with HSA in CFA produced delayed hypersensitivity and permitted lymphocyte stimulation at both 1 and 6 wk. Stimulation was observed with as little as 0.1 microg HSA/ml at the later interval. Administration of 5 mg HSA intravenously at the time of sensitization with 100 microg HSA in IFA reduced but did not eliminate both CBH and lymphocyte stimulation at 1 wk. Antigen-specific inhibition of macrophage migration could be demonstrated with exudates from animals immunized with HSA in CFA, but not with HSA in IFA at 3 wk after sensitization. HSA was cleared from depots of CFA and IFA at similar rates, but significantly more antigen appeared in the plasma and subsequently in the draining lymph nodes following administration in IFA. Conversely, accumulated antigen disappeared more rapidly following CFA immunization.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5316262      PMCID: PMC2138899          DOI: 10.1084/jem.133.2.202

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  AN IN VITRO SYSTEM FOR THE STUDY OF THE MECHANISM OF ANTIGENIC STIMULATION IN THE SECONDARY RESPONSE.

Authors:  R W DUTTON; J D EADY
Journal:  Immunology       Date:  1964-01       Impact factor: 7.397

2.  The mode of action of immunologic adjuvants.

Authors:  J FREUND
Journal:  Bibl Tuberc       Date:  1956

3.  Immunologic unresponsiveness in the adult guinea pig. 3. Variation of the antigen and vehicle of suppression. Induction of unresponsiveness in the adult rat.

Authors:  H F Dvorak; J B Billote; J S McCarthy; M H Flax
Journal:  J Immunol       Date:  1966-07       Impact factor: 5.422

4.  The immunologic significance of antigen induced lymphocyte transformation in vitro.

Authors:  J A Mills
Journal:  J Immunol       Date:  1966-08       Impact factor: 5.422

5.  The relationship between lymphocyte transformation and immune responses. II. Correlations between transformation and humoral and cellular immune responses.

Authors:  D Benezra; I Gery; A M Davies
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

Review 6.  Cell selection by antigen in the immune response.

Authors:  G W Siskind; B Benacerraf
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

Review 7.  Role of adjuvants in the production of delayed hypersensitivity.

Authors:  R G White
Journal:  Br Med Bull       Date:  1967-01       Impact factor: 4.291

8.  Properties of guinea pig 7S antibodies. I. Electrophoretic separation of two types of guinea pig 7S antibodies.

Authors:  B BENACERRAF; Z OVARY; K J BLOCH; E C FRANKLIN
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

9.  Cutaneous basophil hypersensitivity. I. A new look at the Jones-Mote reaction, general characteristics.

Authors:  H B Richerson; H F Dvorak; S Leskowitz
Journal:  J Exp Med       Date:  1970-09-01       Impact factor: 14.307

10.  Occurrence of delayed hypersensitivity during the development of Arthus type hypersensitivity.

Authors:  S B SALVIN
Journal:  J Exp Med       Date:  1958-01-01       Impact factor: 14.307

View more
  11 in total

1.  Acquired resistance to ticks. IV. Skin reactivity and in vitro lymphocyte responsiveness to salivary gland antigen.

Authors:  S K Wikel; J E Graham; J R Allen
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

Review 2.  Basophils in human disease.

Authors:  E B Mitchell; P W Askenase
Journal:  Clin Rev Allergy       Date:  1983-09

3.  Relationships among differentiated T-cell subpopulations. I. Dissociated development of tuberculin type hypersensitivity, Jones-Mote type hypersensitivity and activation of helper function.

Authors:  Y Ohmichi; K Nomoto; H Yamada; K Takeya
Journal:  Immunology       Date:  1976-07       Impact factor: 7.397

4.  Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9.

Authors:  Eleftherios P Diamandis; Robert C Bast; Phil Gold; T Ming Chu; John L Magnani
Journal:  Clin Chem       Date:  2012-11-30       Impact factor: 8.327

5.  Two distinct types of cellular mechanisms in the development of delayed hypersensitivity in mice: requirement of either mast cells or macrophages for elicitation of the response.

Authors:  I Torii; S Morikawa; T Harada; Y Kitamura
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

6.  Cutaneous basophil (Jones-Mote) hypersensitivity after "tolerogenic" doses of intravenous ovalbumin in the guinea pig.

Authors:  H B Richerson
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

7.  Cutaneous basophil hypersensitivity in contact-sensitized guinea pigs. I. Transfer with immune serum.

Authors:  P W Askenase
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

8.  Basophilic leukocytes in allergic contact dermatitis.

Authors:  H F Dvorak; M C Mihm
Journal:  J Exp Med       Date:  1972-02-01       Impact factor: 14.307

9.  Immunologic rejection of diethylnitrosamine-induced hepatomas in strain 2 guinea pigs: participation of basophilic leukocytes and macrophage aggregates.

Authors:  H F Dvorak; A M Dvorak; W H Churchill
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

10.  Heterogeneity of the cellular immune response. I. Kinetics of lymphocyte stimulation during sensitization and recovery from tolerance.

Authors:  R C Bast; E J Manseau; H F Dvorak
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.